The requirements of a specialist breast centre
2020 · The Breast · 192 citations
https://doi.org/10.1016/j.breast.2020.02.003
M
Marko Skelin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
641
Citations
11
h-index
12
i10-index
Marko Skelin is an academic researcher from University of Rijeka. The author has contributed to research in topics: Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments & Atrial Fibrillation Management and Outcomes. The author has an h-index of 11, co-authored 84 publications.
ORCID: 0000-0003-2762-3139Papers by this author
worksProlonged Proton Pump Inhibitor Use and Thrombohemorrhagic Risk in Essential Thrombocythemia and Polycythemia Vera Patients Treated with Long-Term Aspirin: A Pilot Study
2024 · Pharmacology · 1 citations
https://doi.org/10.1159/000535078
No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study
2024 · Heliyon · 1 citations
https://doi.org/10.1016/j.heliyon.2024.e32827
The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19762305
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat